Literature DB >> 3345558

Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene.

R L Williams1, S A Courtneidge, E F Wagner.   

Abstract

The effect of the middle T oncogene of polyoma virus was studied in vivo using a replication-defective selectable retrovirus. Injection of virus into newborn and adult mice resulted in the rapid appearance of cavernous hemangiomas. Infection of embryos did not yield transgenic mice; therefore, embryonal stem (ES) cells were used as an alternative system. Several infected ES cell clones were established that constitutively expressed middle T and its associated tyrosine kinase activity. Chimeric embryos obtained by blastocyst injection of individual ES cell clones were specifically arrested at midgestation, when multiple hemangiomas disrupted blood vessel formation. From these tumors endothelial cell lines were established that retained expression of von Willebrand factor yet were tumorigenic in vivo. These results suggest that middle T acts in endothelial cells as a single-step oncogene and that ES cells provide a valuable system for the study of growth control during embryogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3345558     DOI: 10.1016/0092-8674(88)90536-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  64 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Characterization of novel clonal murine endothelial cell lines with an extended life span.

Authors:  U Cavallaro; V Castelli; A Perilli; R Dossi; R Giavazzi; M S Pepper; M R Soria; R Montesano
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

Review 3.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

4.  Correlation between nitric oxide synthase activity and reduced glutathione level in human and murine endothelial cells.

Authors:  D Ghigo; D Geromin; C Franchino; R Todde; C Priotto; C Costamagna; M Arese; G Garbarino; G P Pescarmona; A Bosia
Journal:  Amino Acids       Date:  1996-09       Impact factor: 3.520

5.  Anti-CD31 delays platelet adhesion/aggregation at sites of endothelial injury in mouse cerebral arterioles.

Authors:  W I Rosenblum; S Murata; G H Nelson; P K Werner; R Ranken; R C Harmon
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

6.  A novel transgenic mice model for venous malformation.

Authors:  Yan An Wang; Jia Wei Zheng; Zhao Liang Fei; Xin Quan Jiang; Zhu Gang Wang; Jian Fei; Zhi Yuan Zhang
Journal:  Transgenic Res       Date:  2008-10-14       Impact factor: 2.788

7.  Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.

Authors:  Franck Lebrin; Marie-José Goumans; Leon Jonker; Rita L C Carvalho; Gudrun Valdimarsdottir; Midory Thorikay; Christine Mummery; Helen M Arthur; Peter ten Dijke
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

8.  Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells.

Authors:  Juan Wen; Yuan Zhao; Jinghe Li; Chunyan Weng; Jingjing Cai; Kan Yang; Hong Yuan; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  Prostate       Date:  2013-02-19       Impact factor: 4.104

Review 9.  Transgenic and knockout mice in the study of neurodegenerative diseases.

Authors:  A Aguzzi; S Brandner; S Marino; J P Steinbach
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

10.  Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines.

Authors:  L Juillerat-Jeanneret; A Aguzzi; O D Wiestler; P Darekar; R C Janzer
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.